Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Novonesis (NVZMY)
OTHER OTC:NVZMY
NVZMY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$54.26 - $72.19
Previous CloseN/A
Volume8.66K
Average Volume (3M)17.69K
Market Cap
$26.00B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)35.3
Beta0.71
Next Earnings
Feb 26, 2025EPS Estimate
0.53Last Dividend Ex-Date
Sep 09, 2024Dividend Yield1.01%
Share Statistics
EPS (TTM)1.58
Shares Outstanding414,555,050
10 Day Avg. Volume14,488
30 Day Avg. Volume17,690
Standard Deviation0.08
R-Squared0.34
Alpha-0.00479
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)5.90
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Novonesis News
PremiumCompany Announcements
Novonesis Reports Strong Q3 Growth in 2024
PremiumPre-Earnings
Is NVZMY a Buy, Before Earnings?---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
<0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
NVZMY FAQ
What was Novonesis’s price range in the past 12 months?
Novonesis lowest stock price was $54.26 and its highest was $72.19 in the past 12 months.
What is Novonesis’s market cap?
Novonesis’s market cap is $26.00B.
When is Novonesis’s upcoming earnings report date?
Novonesis’s upcoming earnings report date is Feb 26, 2025 which is in 3 days.
How were Novonesis’s earnings last quarter?
Currently, no data Available
Is Novonesis overvalued?
According to Wall Street analysts Novonesis’s price is currently Overvalued.
Does Novonesis pay dividends?
Novonesis pays a Semiannually dividend of $0.352 which represents an annual dividend yield of 1.01%. See more information on Novonesis dividends here
What is Novonesis’s EPS estimate?
Novonesis’s EPS estimate is 0.53.
How many shares outstanding does Novonesis have?
Novonesis has 414,555,050 shares outstanding.
What happened to Novonesis’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Novonesis?
Currently, no hedge funds are holding shares in NVZMY
---
Novonesis Stock Smart Score
Company Description
Novonesis
Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark.
---
NVZMY Company Deck
---
NVZMY Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call indicates a positive overall sentiment with strong organic sales growth, a high number of new product launches, and significant contributions from key segments like Household Care and Advanced Protein Solutions. However, there are challenges such as low growth in Human Health Biosolutions and a flat performance in the Agricultural segment, which are noted as areas needing attention.Read More>---
NVZMY Revenue Breakdown
28.53% Household Care
24.83% Bioenergy
22.07% Food, Beverages & Human Health
12.82% Grain & Tech Processing
11.75% Agriculture & Animal Health
---
NVZMY Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering NVZMY
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+11.60%
reiterated a buy rating a year ago
Copying Cezara Lozneanu's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +11.60% per trade.
---